Skip to main content
Equibles

Ashton Thomas Private Wealth, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2019663 SCOTTSDALE, AZ
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$1,347,628
+$206,272 QoQ
Shares Held
2,713
+6.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ashton Thomas Private Wealth, LLC holds $8,943,473 across 10 Biotechnology names. VRTX ranks #3 (15.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 35,756 $4,053,300
2 EXEL
Exelixis, Inc.
 26,778 $1,456,990
3 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		2,713 $1,347,628
4 HALO
Halozyme Therapeutics, Inc.
 16,184 $1,266,721
5 LGND
Ligand Pharmaceuticals Inc
 1,704 $538,617
6 CNSY
Cerenome, Inc.
 34,306 $149,917
7 NAUT
Nautilus Biotechnology, Inc.
 45,000 $84,150
8 MRKR
Marker Therapeutics, Inc.
 16,400 $24,108

All Filings in VRTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,347,628 2,713
2026-03-31 $1,141,356 2,556
2025-12-31 $1,134,760 2,503
2025-09-30 $945,418 2,414
2025-06-30 $944,714 2,122
2025-03-31 $1,135,448 2,342
2024-12-31 $840,434 2,087
2024-09-30 $1,065,498 2,291
2024-06-30 $1,096,336 2,339
2024-03-31 $938,850 2,246
2023-12-31 $791,807 1,946
2023-09-30 $314,009 903
2023-06-30 $313,903 892
2023-03-31 $273,480 868
2022-12-31 $268,276 929
2022-09-30 $252,768 873
2022-06-30 $266,009 944
2022-03-31 $232,002 889